Announcement

Collapse
No announcement yet.

new redness reducing eye drops with no rebound!

Collapse
X
  • Filter
  • Time
  • Show
Clear All
new posts

  • Originally posted by bluebear View Post
    Hey, I've ran out of the drops so not using them at the moment. I'll delay my next purchase due to the $ and I dont have any events coming up...

    I just asked for brimonidine 0.01%, I don't know what the rest of the ingredients are, probably just preservative free drops.
    Hopefully the FDA decision in December comes back as positive and you can just buy it over the counter. It's too expensive and troublesome this way.
    bluebear effect rebound there is?

    Comment


    • Found this: http://www.prnewswire.com/news-relea...300453630.html

      So may be available in 2018?

      Comment


      • I managed to get a script for alphagan p. I added a few drops to dry eye drops and since you can't take the top off those bottles I added it using a syringe. (genius idea) . I havent been able to measure the exact amount I put it but I'll just see how it goes.

        Comment


        • Originally posted by bluebear View Post
          I managed to get a script for alphagan p. I added a few drops to dry eye drops and since you can't take the top off those bottles I added it using a syringe. (genius idea) . I havent been able to measure the exact amount I put it but I'll just see how it goes.
          bluebear i send you a private message please reply thanks

          Comment


          • It's been approved. They named it lumify. "We expect LUMIFY will be available for purchase in major retailers in the second quarter of 2018.Ē

            https://nbherard.com/business/bausch...-redness/43753

            Comment


            • Great news Blue Bear! Iíve been following it behind the scenes. Itís finally coming.

              Comment



              • The FDA has approved Bausch + Lomb's LUMIFY, previously known as Luminesse, as the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness.

                Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (VRX) (VRX.TO), licensed LUMIFY from privately held Eye Therapies Inc.

                Brimonidine, which was first approved by the FDA in 1996 for intraocular pressure (IOP) reduction in glaucoma patients, is available at higher doses in prescription eye care products.

                LUMIFY is expected to be available for purchase in major retailers in the second quarter of 2018.

                Comment

                Working...
                X